For instance, our review found that beta-blockers reduced sudden cardiac death more effectively than ACE inhibitors, as demonstrated by Krum et al. [12]; however, this benefit came at the cost of increased pump failure deaths, suggesting that therapy should be tailored based on specific heart failure phenotypes. Here, ACE is linked to heart failure.